$0.91
-0.0212[-2.28%]
At close: Apr 17
$0.91
0[0.00%]
After Hours: 9:25AM EDT
Mainz Biomed
(NASDAQ:MYNZ)Mainz Biomed Stock (NASDAQ:MYNZ), Earnings Estimates, EPS, and Revenue
Mainz Biomed reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 14
EPS Estimate
$-0.210
Quarterly Revenue Estimate
$300K
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$895.5K
Analyze the earnings history of Mainz Biomed using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/14/2024 | AM | MYNZ | Q1 | -$0.45 | -$0.21 | — | — | $250.10K | $300.00K | — | — | Get Alert |
| 04/09/2024 | AM | MYNZ | Q4 | — | -$0.32 | -$0.24 | 25.00% | — | $270.00K | $214.76K | -20.46% | Get Alert |
| 11/16/2023 | AM | MYNZ | Q3 | -$0.39 | -$0.47 | -$0.39 | 17.02% | $96.00 | $330.00K | $181.67K | -44.95% | Get Alert |
| 08/15/2023 | AM | MYNZ | Q2 | -$0.48 | -$0.42 | -$0.56 | -33.33% | $139.24K | — | $248.94K | — | Get Alert |
| 05/16/2023 | AM | MYNZ | Q1 | -$0.42 | — | -$0.45 | — | $100.56K | — | $250.10K | — | Get Alert |
| 04/10/2023 | AM | MYNZ | FY | -$1.62 | -$1.76 | -$1.86 | -5.68% | $577.35K | $697.50K | $529.88K | -24.03% | Get Alert |
| 09/07/2022 | AM | MYNZ | H1 | -$0.05 | — | -$0.91 | — | $417.33K | — | $239.81K | — | Get Alert |
FAQ
When is Mainz Biomed (NASDAQ:MYNZ) reporting earnings?
Mainz Biomed (MYNZ) is scheduled to report earnings on May 14, 2024. The last reported earnings were for reported on April 9, 2024 for Q4.
What were the latest earnings per share (EPS) for Mainz Biomed (NASDAQ:MYNZ)?
The Actual EPS was $-0.24, which beat the estimate of $-0.32.
What were Mainz Biomed’s (NASDAQ:MYNZ) revenues?
The Actual Revenue was $214.8K, which missed the estimate of $270K.
Browse earnings estimates, EPS, and revenue on all stocks.